https://www.selleckchem.com/pr....oducts/proxalutamide
001). Significant survival improvements in surgery group compared with non-surgery group were observed in patients with lung-only metastasis (adjusted HR = 0.45, P less then .001), bone-only metastasis (adjusted HR = 0.40, P less then .001), and liver-only metastasis (adjusted HR = 0.27, P less then .001), whereas no survival improvement of surgery was found for patients with brain-only metastasis (adjusted HR = 0.57, P = .059) or multiply organ distant metastases (adjusted HR = 0.81, P = .099).The survival benefit fr
Like
Comment
Share
